ENTITY
YiChang HEC ChangJiang Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical (1558 HK)

137
Analysis
Health Care • China
YiChang HEC ChangJiang Pharmaceutical develops, manufactures, and sells pharmaceutical products, focusing on anti-viral, endocrine and metabolic, and cardiovascular diseases. Key products include Kewei (oseltamivir phosphate), Oumeining (telmisartan), and Ertongshu (benzbromarone). The company was founded in 2001 and is headquartered in Dongguan, China.
more
•29 Jul 2024 00:42

Merger Arb Mondays (29 Jul) - China TCM, Canvest, CPMC, GA Pack, Tohokushinsha, Furukawa, Tatsuta

This week, the highest gross spreads are HEC Pharma (126.8%), China TCM (37.3%), Canvest (11.9%), GAPack (11.8%), Asia Cement China (10.7%),...

Logo
821 Views
Share
•22 Jul 2024 00:42

Merger Arb Mondays (22 Jul) - China TCM, GA Pack, Huafa, Samson, CPMC, Fancl, Tatsuta, Capitol

This week, the highest gross spreads are HEC Pharma (122.5%), China TCM (31.8%), Asia Cement (12.6%), Canvest (11.1%), GA Pack (10.9%), Malaysia...

Logo
599 Views
Share
•15 Jul 2024 13:10

BUY/SELL/HOLD: Hong Kong Stocks Update (July 15)

Hong Kong markets continue to trade at a 25% discount to analysts year end targets.  Bud APAC, Anta Sports, Sunny Optical and Shineway RX are...

Logo
550 Views
Share
•15 Jul 2024 00:28

Merger Arb Mondays (15 Jul) - China TCM, Canvest, Henlius, Hollysys, Second Chance, Anasarda, Rex

This week, the highest gross spreads are HEC Pharma (134.8%), China TCM (32.2%), Canvest (13.4%), A8 New Media (12.5%), Asia Cement (11.8%), GA...

Logo
664 Views
Share
•12 Jul 2024 09:36

Henlius (2696 HK): Here Comes The Scrip Option

This is trading wide-ish at 8.8%/28.8% currently (assuming mid-Nov payment), ostensibly due to the timing on the regulatory approvals - TCM (570...

Logo
693 Views
Share
x